CLINICAL_TRIALS ClinicalTrials.gov record update

The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post Covid-19 Smell and Taste Dysfunctions

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05104424
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:25.339403+00:00
Published At: 2021-11-03T00:00:00+00:00
Record Updated At: 2021-11-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Smell Dysfunction", "Taste Disorders", "Taste Disorder, Secondary, Sweet", "Taste Disorder, Secondary, Bitter", "Smell Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-11-03"
protocolSection.identificationModule.nctId: "NCT05104424"
protocolSection.identificationModule.officialTitle: "The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post Covid-19 Smell and Taste Dysfunctions"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.